Overgrowth of prenatal onset associated with submicroscopic 9q22.3 deletion

American Journal of Medical Genetics, Part A

Volumn 155, Issue 4, 2011, Pages 903-905

  Kosaki, Rika ^a   Fujita, Hideki ^a   Ueoka, Katsuhiko ^a   Torii, Chiharu ^b   Kosaki, Kenjiro ^b  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APGAR SCORE; BASAL CELL NEVUS SYNDROME; CASE REPORT; CHILD; CHROMOSOME 9Q; CHROMOSOME 9Q22.3; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL MALFORMATION; COPY NUMBER VARIATION; FACE DYSMORPHIA; FRONTAL BOSSING; GENE; GENE DELETION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GESTATIONAL AGE; GROWTH RETARDATION; HUMAN; HYDRONEPHROSIS; HYPERTELORISM; INFANT; LETTER; MALE; MICROGNATHIA; MUSCLE HYPOTONIA; PHENOTYPE; POLYDACTYLY; PRENATAL PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PTCH1 GENE; WEBBED NECK;

CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; COMPARATIVE GENOMIC HYBRIDIZATION; GENE DELETION; HUMANS; INFANT; MALE; OBESITY; RECEPTORS, CELL SURFACE;

EID: 79953318388     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.33835     Document Type: Letter

References (7)

1. Chen CP, Lin SP, Wang TH, Chen YJ, Chen M, Wang W. 2006. Perinatal findings and molecular cytogenetic analyses of de novo interstitial deletion of 9q (9q22.3→q31.3) associated with Gorlin syndrome. Prenata Diagn 26: 725-729.
2. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, Yoon D, Lee MH, Kim DJ, Park M, Cha SH, Kim JW, Han BG, Min H, Ahn Y, Park MS, Han HR, Jang HY, Cho EY, Lee JE, Cho NH, Shin C, Park T, Park JW, Lee JK, Cardon L, Clarke G, McCarthy MI, Lee JY, Oh B, Kim HL. 2009. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 41: 527-534.
3. Farrell SA, SiegelpBartelt J, Teshima I. 1991. Patients with deletions of 9q22q34 do not define a syndrome: Three case reports and a literature review. Clin Genet 40: 207-214.
4. Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kase R, DiGiovanna JJ, Bale AE, Bale SJ. 1997. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 69: 299-308.
5. Redon R, Baujat G, Sanlaville D, Le Merrer M, Vekemans M, Munnich A, Carter NP, Cormier-Darie V, Colleaux L. 2006. Interstitial 9q22.3 microdeletion: Clinical and molecular characterization of a newly recognized overgrowth. Eur J Hum Genet 14: 759-767.
6. Shimojima K, Adachi M, Tanaka M, Tanaka Y, Kurosawa K, Yamamoto T. 2009. Clinical features of microdeletion 9q22.3(pat). Clin Genet 75: 384-393.
7. Yamamoto K, Yoshihashi H, Furuya N, Adachi M, Ito S, Tanaka Y, Masuno M, Chiyo H, Kurosawa K. 2009. Further delineation of 9q22 deletion syndrome associated with basal cell nevus (Gorlin) syndrome: Report of two cases and review of the literature. Congenit Anom 49: 8-14.